Clinical trial Recruiting at 1 site Observational Ages 18 and up

Femoral vein-to-artery diameter ratio to predict fluid responsiveness

Official title: Prediction of Fluid Responsiveness Using the Femoral Vein-to-Artery Diameter Ratio: A Prospective Observational Study

Run by Istanbul University - Cerrahpasa · NCT07546656 · Data updated 2026-11-12

This project will test whether a bedside ultrasound measurement of the femoral vein-to-artery diameter ratio can tell if mechanically ventilated ICU patients with acute circulatory failure or shock will increase their cardiac output after a 500 mL fluid bolus.

More Shock trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedMay 1, 2026
Main results expectedJanuary 31, 2027
Study endsMarch 1, 2027
Registry record updatedMay 11, 2026
Trial IDNCT07546656 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults in the study ICU on invasive mechanical ventilation with acute circulatory failure or shock who already have PiCCO monitoring and a planned clinical fluid challenge are the ideal candidates.

Probably not a fit

Patients who are not mechanically ventilated, lack PiCCO monitoring, have contraindications to femoral ultrasound (for example groin injury) or cannot undergo a fluid challenge are unlikely to benefit from these results.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center observational study enrolling mechanically ventilated adult ICU patients with acute circulatory failure or shock who already have PiCCO monitoring and a clinician-planned fluid challenge. Baseline cardiac index will be recorded with PiCCO and femoral vein and artery diameters measured by bedside ultrasound, with each ultrasound repeated at least three times and averaged. A 500 mL balanced crystalloid will be given over 10 minutes and cardiac index remeasured, with fluid responsiveness defined as a >10% increase in cardiac index. The diagnostic performance of the femoral vein-to-artery diameter ratio will be compared to the PiCCO-derived change in cardiac index, and no additional invasive procedures will be performed for research purposes.

Why it matters

Potential benefit: If successful, this simple ultrasound ratio could provide a quick bedside tool to help clinicians choose who will benefit from fluids and avoid unnecessary fluid loading.

How similar studies have gone: Other ultrasound-based markers such as IVC or venous size indices have shown mixed accuracy, and the femoral vein-to-artery ratio is a relatively novel bedside parameter with limited prior validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 18 years or older
* Admission to the intensive care unit where the study is being conducted
* Receiving invasive mechanical ventilation
* Clinical indication for a fluid challenge due to acute circulatory failure or shock, as determined by the responsible intensive care physician
* PiCCO monitoring already in place as part of routine clinical care
* Clinical conditions allowing collection of pre- and post-fluid challenge cardiac index and ultrasonographic measurements
* Technical feasibility of femoral vein and femoral artery diameter measurements by ultrasonography

Exclusion Criteria:

* Age younger than 18 years
* Failure to obtain written informed consent from the patient or legally authorized representative before enrollment
* Absence of PiCCO monitoring as part of routine clinical care or no clinical plan for fluid challenge
* Inability to complete pre- and post-fluid challenge measurements (e.g., early death, urgent surgery, transfer)
* Local conditions preventing reliable femoral ultrasonographic assessment, including open wound, infection, dressing, major anatomic obstacle, poor image quality, known femoral vein thrombosis, or severe vascular pathology on the relevant side
* Conditions likely to significantly impair the reliability of thermodilution measurements (e.g., severe tricuspid regurgitation or significant intracardiac shunt)
* Major treatment changes during the fluid challenge that preclude comparable measurements (e.g., major vasopressor dose change, major ventilator setting change, new arrhythmia)
* Missing or inadequate data judged by the investigators to compromise data integrity, including absence of measurements required for the primary outcome

Where it's running

  • Istanbul University Cerrahpasa Medical Faculty
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.